• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌中的金属蛋白酶。

Metalloproteinases in Ovarian Cancer.

机构信息

Harper Cancer Research Institute, University of Notre Dame, South Bend, IN 46617, USA.

Department of Preprofessional Studies, University of Notre Dame, Notre Dame, IN 46556, USA.

出版信息

Int J Mol Sci. 2021 Mar 26;22(7):3403. doi: 10.3390/ijms22073403.

DOI:10.3390/ijms22073403
PMID:33810259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8036623/
Abstract

Proteases play a crucial role in the progression and metastasis of ovarian cancer. Pericellular protein degradation and fragmentation along with remodeling of the extracellular matrix (ECM) is accomplished by numerous proteases that are present in the ovarian tumor microenvironment. Several proteolytic processes have been linked to cancer progression, particularly those facilitated by the matrix metalloproteinase (MMP) family. These proteases have been linked to enhanced migratory ability, extracellular matrix breakdown, and development of support systems for tumors. Several studies have reported the direct involvement of MMPs with ovarian cancer, as well as their mechanisms of action in the tumor microenvironment. MMPs play a key role in upregulating transcription factors, as well as the breakdown of structural proteins like collagen. Proteolytic mechanisms have been shown to enhance the ability of ovarian cancer cells to migrate and adhere to secondary sites allowing for efficient metastasis. Furthermore, angiogenesis for tumor growth and development of metastatic implants is influenced by upregulation of certain proteases, including MMPs. While proteases are produced normally in vivo, they can be upregulated by cancer-associated mutations, tumor-microenvironment interaction, stress-induced catecholamine production, and age-related pathologies. This review outlines the important role of proteases throughout ovarian cancer progression and metastasis.

摘要

蛋白酶在卵巢癌的进展和转移中起着至关重要的作用。细胞周围蛋白质的降解和碎裂以及细胞外基质(ECM)的重塑是由许多存在于卵巢肿瘤微环境中的蛋白酶完成的。许多蛋白水解过程与癌症的进展有关,特别是那些由基质金属蛋白酶(MMP)家族促进的过程。这些蛋白酶与增强的迁移能力、细胞外基质的破坏以及肿瘤支持系统的发展有关。几项研究报告了 MMP 与卵巢癌的直接关系,以及它们在肿瘤微环境中的作用机制。MMP 在上调转录因子以及胶原等结构蛋白的分解中起着关键作用。蛋白水解机制已被证明可增强卵巢癌细胞迁移和附着到次级部位的能力,从而促进有效的转移。此外,肿瘤生长和转移植入物的血管生成受到某些蛋白酶(包括 MMP)的上调的影响。虽然蛋白酶在体内正常产生,但它们可以通过与癌症相关的突变、肿瘤微环境相互作用、应激诱导的儿茶酚胺产生以及与年龄相关的病理来上调。这篇综述概述了蛋白酶在卵巢癌进展和转移过程中的重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c7/8036623/2b5272867499/ijms-22-03403-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c7/8036623/bf97bcc4babe/ijms-22-03403-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c7/8036623/5cf3be1dcaa8/ijms-22-03403-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c7/8036623/8d34594ae2b8/ijms-22-03403-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c7/8036623/2b5272867499/ijms-22-03403-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c7/8036623/bf97bcc4babe/ijms-22-03403-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c7/8036623/5cf3be1dcaa8/ijms-22-03403-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c7/8036623/8d34594ae2b8/ijms-22-03403-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c7/8036623/2b5272867499/ijms-22-03403-g004.jpg

相似文献

1
Metalloproteinases in Ovarian Cancer.卵巢癌中的金属蛋白酶。
Int J Mol Sci. 2021 Mar 26;22(7):3403. doi: 10.3390/ijms22073403.
2
Ovarian cancer: involvement of the matrix metalloproteinases.卵巢癌:基质金属蛋白酶的作用
Reproduction. 2015 Aug;150(2):R55-64. doi: 10.1530/REP-14-0546. Epub 2015 Apr 27.
3
Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.基质金属蛋白酶(MMP - 2、MMP - 9、MT1 - MMP)及其抑制剂(TIMP - 1、TIMP - 2)在卵巢常见上皮性肿瘤中的表达
Int J Oncol. 2000 Oct;17(4):673-81.
4
Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.下一代基质金属蛋白酶抑制剂——新策略带来新前景。
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1927-1939. doi: 10.1016/j.bbamcr.2017.06.009. Epub 2017 Jun 19.
5
Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer.基质金属蛋白酶与卵巢癌发生发展的关系
Braz J Med Biol Res. 2017 May 18;50(6):e6104. doi: 10.1590/1414-431X20176104.
6
Matrix metalloproteinases.基质金属蛋白酶
Exp Suppl. 2012;103:1-33. doi: 10.1007/978-3-0348-0364-9_1.
7
The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.金属蛋白酶及其内源性抑制剂的多方面作用:卵巢癌进展的研究视角。
Int J Mol Sci. 2018 Feb 2;19(2):450. doi: 10.3390/ijms19020450.
8
Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression.基质金属蛋白酶在癌症进展中塑造肿瘤微环境。
Int J Mol Sci. 2021 Dec 23;23(1):146. doi: 10.3390/ijms23010146.
9
Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer.基质金属蛋白酶在肿瘤进展中的作用:聚焦于皮肤基底细胞癌和鳞状细胞癌
Exp Dermatol. 2003 Apr;12(2):109-25. doi: 10.1034/j.1600-0625.2003.120201.x.
10
Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression.通过胶原蛋白诱导的EGR1表达对卵巢癌细胞中膜型1基质金属蛋白酶活性的微环境调节
J Biol Chem. 2007 Feb 16;282(7):4924-4931. doi: 10.1074/jbc.M608428200. Epub 2006 Dec 11.

引用本文的文献

1
Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics.FOXM1在卵巢癌诊断与治疗中的研究进展
Front Oncol. 2025 Jun 19;15:1598868. doi: 10.3389/fonc.2025.1598868. eCollection 2025.
2
Research Progress of Traditional Chinese Medicine Monomer Inhibiting Metastatic Colonization of Ovarian Cancer Cells Based on Cell Biology.基于细胞生物学的中药单体抑制卵巢癌细胞转移定植的研究进展
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251344953. doi: 10.1177/15347354251344953. Epub 2025 Jun 30.
3
Matrix Metalloproteinases 1 and 3 in Ovarian Cancer: Diagnostic and Prognostic Potential of Genetic Variants and Expression Profiling.

本文引用的文献

1
With Great Age Comes Great Metastatic Ability: Ovarian Cancer and the Appeal of the Aging Peritoneal Microenvironment.年龄越大,转移能力越强:卵巢癌与衰老腹膜微环境的吸引力
Cancers (Basel). 2018 Jul 10;10(7):230. doi: 10.3390/cancers10070230.
2
Aging Increases Susceptibility to Ovarian Cancer Metastasis in Murine Allograft Models and Alters Immune Composition of Peritoneal Adipose Tissue.衰老增加了小鼠同种异体移植模型中卵巢癌转移的易感性,并改变了腹膜脂肪组织的免疫组成。
Neoplasia. 2018 Jun;20(6):621-631. doi: 10.1016/j.neo.2018.03.007. Epub 2018 May 10.
3
Monoclonal antibodies against metzincin targets.
卵巢癌中的基质金属蛋白酶1和3:基因变异与表达谱分析的诊断和预后潜力
Diagnostics (Basel). 2025 Jun 15;15(12):1521. doi: 10.3390/diagnostics15121521.
4
Spotlight on Proteases: Roles in Ovarian Health and Disease.蛋白酶聚焦:在卵巢健康与疾病中的作用
Cells. 2025 Jun 18;14(12):921. doi: 10.3390/cells14120921.
5
Upregulation of MMP3 Promotes Cisplatin Resistance in Ovarian Cancer.基质金属蛋白酶3的上调促进卵巢癌顺铂耐药
Int J Mol Sci. 2025 Apr 24;26(9):4012. doi: 10.3390/ijms26094012.
6
Durotaxis and extracellular matrix degradation promote the clustering of cancer cells.基质硬度感应和细胞外基质降解促进癌细胞聚集。
iScience. 2025 Jan 24;28(3):111883. doi: 10.1016/j.isci.2025.111883. eCollection 2025 Mar 21.
7
Regulating the expression of matrix metalloproteinases to inhibit ovarian carcinoma using isoquinoline alkaloid from Allium ascalonicum.利用小根蒜异喹啉生物碱调控基质金属蛋白酶的表达以抑制卵巢癌
Sci Rep. 2025 Mar 18;15(1):9228. doi: 10.1038/s41598-025-94111-0.
8
Tumor Microenvironment Responsive Key Nanomicelles for Effective Against Invasion and Metastasis in Ovarian Cancer Using Mice Model.用于利用小鼠模型有效对抗卵巢癌侵袭和转移的肿瘤微环境响应性关键纳米胶束
Int J Nanomedicine. 2025 Jan 7;20:215-238. doi: 10.2147/IJN.S470219. eCollection 2025.
9
Diagnostic Utility of Metalloproteinases from Collagenase Group (MMP-1, MMP-8 and MMP-13) in Biochemical Diagnosis of Ovarian Carcinoma.胶原酶组金属蛋白酶(MMP-1、MMP-8和MMP-13)在卵巢癌生化诊断中的诊断效用
Cancers (Basel). 2024 Nov 26;16(23):3969. doi: 10.3390/cancers16233969.
10
Molecular mechanisms of cisplatin resistance in ovarian cancer.卵巢癌中顺铂耐药的分子机制。
Genes Dis. 2023 Aug 2;11(6):101063. doi: 10.1016/j.gendis.2023.06.032. eCollection 2024 Nov.
针对金属蛋白酶靶点的单克隆抗体。
Br J Pharmacol. 2019 Jan;176(1):52-66. doi: 10.1111/bph.14186. Epub 2018 Apr 2.
4
PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state.PAX2维持小鼠输卵管上皮细胞的分化,并抑制其向干细胞样状态的转变。
Oncotarget. 2017 Aug 10;8(44):76881-76897. doi: 10.18632/oncotarget.20173. eCollection 2017 Sep 29.
5
E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness.E-钙黏蛋白:一种与卵巢癌进展、扩散及侵袭性相关的决定性分子。
PLoS One. 2017 Sep 21;12(9):e0184439. doi: 10.1371/journal.pone.0184439. eCollection 2017.
6
Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics.膜型1基质金属蛋白酶(MT1-MMP)胞质尾的翻译后修饰影响卵巢癌多细胞聚集体动力学。
J Biol Chem. 2017 Aug 11;292(32):13111-13121. doi: 10.1074/jbc.M117.800904. Epub 2017 Jun 27.
7
Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.上皮性卵巢癌腹膜转移器官型模型中的钙黏蛋白组成与多细胞聚集体侵袭
Oncogene. 2017 Oct 19;36(42):5840-5851. doi: 10.1038/onc.2017.171. Epub 2017 Jun 19.
8
Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer.基质金属蛋白酶与卵巢癌发生发展的关系
Braz J Med Biol Res. 2017 May 18;50(6):e6104. doi: 10.1590/1414-431X20176104.
9
Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts.上皮-间质转化所诱导的运动性和干细胞特性需要脂筏的去稳定化。
Oncotarget. 2016 Aug 9;7(32):51553-51568. doi: 10.18632/oncotarget.9928.
10
Anti-angiogenic agents in ovarian cancer: past, present, and future.卵巢癌中的抗血管生成药物:过去、现在与未来
Ann Oncol. 2016 Apr;27 Suppl 1(Suppl 1):i33-i39. doi: 10.1093/annonc/mdw093.